SACCI Bio Co., Ltd. announced private placement of 570,000 common shares at a price of KRW 5,000 per share for gross proceeds of KRW 2,850,000,000 on July 13, 2021. The transaction will include participation from existing investor Jeisys Medical Inc. for 419,000 shares, individual investor Aki Uchida for 4,000 shares, Sung-Jun Park and 34 individuals for 147,000 shares through third party allocation. The expected payment date is July 14, 2021. The transaction has been approved by the board of directors of the company.